Image Image Image Image Image
Scroll to Top

To Top

Future of Ag

07

Nov
2019

In Blog
Featured
Future of Ag

By Admin

Times Argus: High-tech chestnuts: US to consider genetically altered tree

On 07, Nov 2019 | In Blog, Featured, Future of Ag | By Admin

SYRACUSE, N.Y. (AP) — Chestnuts harvested from high branches on a chilly fall morning look typical: they’re marble sized, russet colored and nestled in prickly burs. But many are like no other nuts in nature.

In a feat of genetic engineering, about half the chestnuts collected at this college experiment station feature a gene that provides resistance to blight that virtually wiped out the American chestnut tree generations ago.

Researchers at New York state’s College of Environmental Science and Forestry will soon seek federal clearance to distribute thousands of modified trees as part of a restoration effort — a closely-watched move that could expand the frontier for genetically engineered plants beyond farms and into forests. The precedent-setting case adds urgency to a question scientists have already been grappling with:

Should genetic engineering be used in the wild to help save or restore trees?

Opponents warn of starting “a massive and irreversible experiment” in a highly complex ecosystem. Proponents see a technology already ubiquitous in the supermarket that could help save forests besieged by invasive pests.

“We have this technology, it’s a very powerful technology, and we can use that now to save a species,” said Professor William Powell, a molecular plant biologist who directs the American Chestnut Research and Restoration Project at the college.

The researchers will ask the U.S. Department of Agriculture to assess an American chestnut tree with a gene from wheat that helps it tolerate cryphonectria parasitica, a fungus unwittingly imported to the United States over 100 years ago.

The blight decimated a towering tree species once dominant in forests from Maine to Georgia. Nuts from up to 4 billion trees fattened hogs, and its sturdy wood was used to build cabins. Yet by the time Nat King Cole crooned about “chestnuts roasting on an open fire” after World War II, trees were doomed by the blight. Surviving trees today are typically shrubs sprouting from old roots, yet to be infected.

Long-running efforts to breed American chestnut trees with the blight tolerance of Chinese chestnut trees are more complicated than once appreciated. That’s because the Chinese tree’s tolerance comes from a suite of genes, instead of one or two.

Powell and his research partner Charles Maynard began working on a complementary track decades ago at the request of the New York chapter of the American Chestnut Foundation. The added wheat gene enables trees to produce an enzyme that breaks down harmful acid released by the fungus.

Right now, the trees are tightly regulated. Modified trees grow behind the fence of the college’s experiment station near trees without the added gene. Researchers breed the two types of trees for genetic diversity. But flowering branch tips are covered with bags that keep pollen from blowing away. Chestnuts grow and are harvested in the same bags.

About half the chestnuts will inherit the gene, the researchers say.

The researchers will ask the USDA’s Animal and Plant Health Inspection Service to evaluate the risks of the modified tree. They want the agency to lift the regulations it now imposes.

“What we have to make clear is that it’s not going to be any different than the trees produced through conventional means,” Powell said.

The USDA commonly authorizes genetically engineered crops. The vast majority of commercial corn and soybean acreage in the United States is used to grow crops engineered to be tolerant to herbicides or insects. There are even some genetically engineered plantation trees, such as papayas resistant to ringspot virus.

But engineered trees are not intentionally planted in the forests for conservation. That could change as genetic manipulation becomes more common and trees are increasingly threatened by climate change and invasive pests.

“If the chestnut is approved … I think it’s accurate to say that it does help pave the way for other biotech trees,” said Jason Delborne, an associate professor of science, policy and society at North Carolina State University. Delborne served on a National Academies of Science, Engineering and Medicine committee that this year released a report that said biotechnology has a potential to help protect forests but recommended more study and investment.

Some scientists are concerned about the long-term effects of a re-introducing a tree into the woods that can live for more than 200 years. How will the new trees interact with the species that replaced the long-gone chestnuts? What if the trees die off again in 50 years?

Forest eco-systems are incredibly complex and the current regulatory framework is not up to the task of evaluating the environmental and societal risks, said biotechnology and sustainable agriculture expert Doug Gurian-Sherman.

“I think we have to step back and ask whether our ability to manipulate things is getting ahead of our ability to understand their impacts,” said Gurian-Sherman, a former senior scientist for the Union of Concerned Scientists.

Rachel Smolker, a co-director of the advocacy group Biofuelwatch and co-author of a report critical of the tree’s release, is concerned that the chestnut tree — with its cozy public image — could be a “Trojan horse” for other trees engineered for commercial use instead of conservation.

Many scientists see biotech as a promising tool left on the shelf, partly due to opposition they say is grounded more in emotion than science.

Meanwhile, trees are dying from scourges such as the emerald ash borer and the spotted lantern fly, and some scientists say biotech could help where other efforts have failed.

“Compared to what’s happening in the world with pests and climate change, I think the risks of making a mistake due to tweaking a gene wrong are so small compared to the risks of doing nothing,” said Steven Strauss, a forest biotechnologist at Oregon State University in Corvallis. Strauss is prominent in efforts to overturn biotech tree bans on certified commercial forest land.

If the application clears the USDA, the tree still needs to be considered by the Food and Drug Administration and it may need to be reviewed by the Environmental Protection Agency. Powell believes the review could take two to four years.

A green light from the government would clear the way for distribution of the genetically engineered seedlings, pollen, or scions for grafting to volunteers around the chestnut’s traditional range.

In rural upstate New York, Allen Nichols is waiting.

Nichols, president of the New York chapter of the American Chestnut Foundation, has about 100 chestnut trees on a rise by his house. Thanks to his diligent care, some lived long enough to produce chestnuts this year. Other trees are dying while others sprout anew — a steady cycle of life, blight and renewal in a rural orchard.

The 69-year-old -retiree looks forward to the day he can graft the genetically engineered tree onto his stock, letting the pollen drift in the wind and bringing back a healthy tree his parents talked fondly about.

“If we can do it, we should do it,” Nichols said as he surveyed his trees. “We owe it to the forest to try to correct some of the damage that we’ve done.”

https://www.timesargus.com/news/national/high-tech-chestnuts-us-to-consider-genetically-altered-tree/article_1879cee2-9a14-5536-8026-1bead47bee78.html#utm_source=newsletter&utm_campaign=the-daily&utm_medium=email&utm_content=headline

Farm to Food Gene Editing: The Future of Agriculture

On 25, Apr 2019 | In Blog, Featured, Future of Ag, GMO’s and The Environment | By Admin

Curious about what gene editing is? Watch this video to learn how CRISPR is helping farmers grow better crops to feed our growing population.

23

Apr
2019

In Featured
Future of Ag
latest-news

By Admin

USA Today: Earth Day for a dairy farmer: Thinking decades down the line

On 23, Apr 2019 | In Featured, Future of Ag, latest-news | By Admin

April 22, 2019

What U.S. dairy farmers of today are doing to preserve our environment

I’ve had the honor of working with dairy farmers for years, and a lot of what you think about them is true. They’re modest. They’re connected to the earth. And they work incredibly hard. Every day, they’re up before dawn, working 12 and 14-hour days, whether it’s 90 degrees out or 50 degrees below zero.
 
They choose this hard work because they believe in the importance of providing nutritious, great-tasting food, like the milk in your child’s glass or the slice of cheese on her favorite sandwich.

What you might not know is that dairy farmers are working just as hard to ensure our children inherit a healthy planet. They know it’s the right thing to do. And when 95% of dairy farms are family-owned, they do it to ensure the land is there for their children. 

But the issues facing our planet require more than just individual action, which is why the U.S. dairy community has made sustainability an industry-wide priority. Years’ worth of investments, research — and, yes, hard work — have allowed us to address critical environmental issues, like climate change and greenhouse gas emissions. 

Dairy farmer and environmental scientist Tara Vander Dussen with her family on their farm, Rajen Dairy.

Dairy farmer and environmental scientist Tara Vander Dussen with her family on their farm, Rajen Dairy. (Photo: Innovation Center for U.S. Dairy)

Ten years ago, the Innovation Center for U.S. Dairy — created by dairy farmers to identify best practices and unite around common goals — established a voluntary yet aggressive goal for the industry. The U.S. dairy community would reduce greenhouse gas emissions intensity 25% by 2020. 

Today, we are on track to meet that goal. 

In making the investments necessary to meet the goal set, U.S. dairy farmers have become global leaders in reducing greenhouse gas emissions. According to a report earlier this year from the United Nations’ Food and Agriculture Organization (FAO), Climate Change and the Global Dairy Cattle Sector, North American dairy farmers are the only ones who have reduced both total GHG emissions and intensity over the last decade.

Dairy farmer and nutritionist Rosemarie Burgos-Zimbelman, who has dedicated her life to dairy nutrition.

Dairy farmer and nutritionist Rosemarie Burgos-Zimbelman, who has dedicated her life to dairy nutrition. (Photo: Innovation Center for U.S. Dairy)

It’s not just greenhouse gas emissions. U.S. dairy farmers work more closely with animals than just about anyone, and they know that while they are taking care of the cows, the cows are taking care of them. That’s why they created the National Dairy FARM (Farmers Assuring Responsible Management) Program, the first internationally-certified animal welfare program in the world.

The U.S. dairy community’s commitment to sustainability isn’t new. It has been going on for generations. Indeed, producing milk now uses fewer natural resources than it ever has before. Over the course of the lifetime of today’s average dairy farmer, producing a gallon of milk now requires 65% less water, 90% less land and 63% less carbon emissions. 

While progress has been made, there is still a lot to be done. That’s why the U.S. dairy community and dairy farmers are committed to identifying new solutions, technologies and partnerships that will continue to advance our commitment to sustainability.  

So why do America’s dairy farmers work so hard to farm more sustainably? Why spend countless hours looking for innovative ways to be more efficient when they’ve already put in a 14-hour day?

It’s not because anyone told them to, or because regulation forced them to. It’s because so many of them are farming land their families have been farming for generations. They know they’re just the latest people entrusted as stewards of the earth. Farmers came before them, and farmers will come after them. Sure, they have more information than any of their predecessors did, and they are now tackling challenges, from climate change to global trade, that their forefathers could scarcely dream of. But the responsibility of today’s dairy farmer — leaving the planet better than they found it — is no different. 

This Earth Day, and every day, America’s dairy farmers are living up to that responsibility. May they never tire.

Vilsack is the former U.S. Secretary of Agriculture and the current president and CEO of the U.S. Dairy Export Council.

https://www.usatoday.com/story/sponsor-story/innovation-center-for-us-dairy/2019/04/22/earth-day-dairy-farmer-thinking-decades-down-line/3521007002/?mvt=i&mvn=400ecb525a984b48bdeecbe607c274e8&mvp=NA-GANNLOCASITEMANA-11238693&mvl=Size-2×3+%5BDigital+Front+Redesign+Tile%5D

27

Nov
2018

In Blog
Featured
Future of Ag

By Admin

Science makes bread taste better

On 27, Nov 2018 | In Blog, Featured, Future of Ag | By Admin

Renegade bakers and geneticists develop whole-wheat loaves you’ll want to eat

26

Nov
2018

In Blog
Featured
Future of Ag
GMO Labeling

By Admin

Boston Globe: 3 policies for the future

On 26, Nov 2018 | In Blog, Featured, Future of Ag, GMO Labeling | By Admin

Food is going high-tech — policy needs to catch up with it

17

May
2018

In Featured
Future of Ag

By Admin

VT Digger: Tebbetts, Moore & Schirling: Innovating for water quality

On 17, May 2018 | In Featured, Future of Ag | By Admin

Editor’s note: This commentary is by Anson Tebbetts, secretary of the Vermont Agency of Agriculture, Food & Markets; Julie Moore, secretary of the Agency of Natural Resources; and Mike Schirling, secretary of the Department of Commerce and Community Development.

From Vermont’s inception, freedom and unity have spurred innovation. John Deere invented the tractor. Ben and Jerry created world-class ice cream. Environmental leaders like George Perkins Marsh defined conservation. The state’s rich history highlights how Vermonters and their values have led the way.

Innovation continues today. Farmers are working with engineers, scientists and researchers on projects that improve the environment while improving their finances. Biodigesters transform manure to electricity. Perennial plants and grasses transform bare soils into buffers to protect rivers, and lasers help milk cows.

Our next challenge is phosphorous innovation. Phosphorus is essential for plant growth, and both human and animal health. Too much phosphorus can be harmful to our waterways. Farmers deploy a bevy of conservation measures to keep phosphorous on their fields. Adopting these best management practices to protect water has also improved soil. And efforts are currently underway to spark further innovation in phosphorus management, building on that progress.

Gov. Phil Scott has challenged the agencies of Natural Resources, Agriculture and Commerce to find engineers, innovators and entrepreneurs who can work with farmers to deploy new and innovative approaches to capture and reuse phosphorus. That innovation could take the form of extracting phosphorus from manure, processing waste to produce energy, and perhaps generating revenue and creating jobs. Possible approaches include production of compost, fertilizers and bio-char. There are many companies working on these solutions and, through the Phosphorus Innovation Challenge, Vermont is at the table.

In phase one of this project the state has made $250,000 available for “proof-of-concept” grants to support several projects. The state is accepting proposals for this seed money over the next two months. A panel comprised of scientists, entrepreneurs, and business experts will help guide the selection. If you would like to take up the challenge, we look forward to hearing from you!

We know that achieving Vermont’s clean water goals will require us to deploy both traditional conservation measures and new methods and ideas. We look forward to a day when products or processes that ensure clean water and farm viability are the standard, taking their place alongside other tools on our farms, many of which have their roots in Vermont. Freedom and unity includes innovation which continues to move Vermont forward, as it has for centuries, improving our environment, families and communities.

Tebbetts, Moore & Schirling: Innovating for water quality

04

May
2018

In Blog
Featured
Future of Ag

By Admin

60 Minutes: CRISPR: The gene-editing tool revolutionizing biomedical research

On 04, May 2018 | In Blog, Featured, Future of Ag | By Admin

A new tool could be the key to treating genetic diseases and may be the most consequential discovery in biomedicine this century.

It’s challenging to tell a story about something that’s invisible to the naked eye and tricky to explain. But it’s one we undertook, because rarely does a discovery come along that could revolutionize medicine.  It’s called CRISPR and it stands for Clustered Regularly Interspaced Short Palindromic Repeats. CRISPR sounds more like a refrigerator compartment than a gene-editing tool, but it’s giving scientists power they could only imagine before – to easily edit DNA – allowing them to reprogram the genetic code of living things. That’s opening up the possibility of curing genetic diseases. Some researchers are even using it to try to prevent disease entirely by correcting defective genes in human embryos. We wanted to see for ourselves, so we went to meet a scientist at the center of the CRISPR craze.

“There are about 6,000 or more diseases that are caused by faulty genes. The hope is that we will be able to address most if not all of them.”

Bill Whitaker: This is CRISPR?

Feng Zhang: This has CRISPR in it.

Bill Whitaker: So– this is what’s revolutionizing science and biomedicine?

Feng Zhang: This is what many people are using– in research — and trying to develop treatments.

Bill Whitaker: That’s wild.

Feng Zhang: Yeah.

That little vial is igniting a big revolution that is likely to change the way doctors treat disease in the future. One of the brains behind it, is baby-faced Feng Zhang.

crisprpreview.jpg

Feng Zhang speaks with correspondent Bill Whitaker

 CBS NEWS

At 36, he’s already a tenured professor at MIT and a scientific celebrity because he figured out a way to override human genetic instructions using CRISPR.

Bill Whitaker: So, the CRISPR is not the liquid, the CRISPR is in the–

Feng Zhang: It’s dissolved in the liquid. There are probably billions of molecules of CRISPR…

Bill Whitaker: Billions?

BOTH: In here.

Feng Zhang: That’s right. And the way we use it is we take the liquid and apply it to cells.

For the last seven years, Zhang has been working on CRISPR at the Broad Institute in Cambridge, Massachusetts. It’s a research mecca brimming with some of the brightest scientific minds from Harvard and MIT on a mission to fight disease. CRISPR is making medical research faster, cheaper, easier. Zhang’s colleagues predict it will help them tackle diseases like cancer and Alzheimer’s.  

Bill Whitaker: How many diseases are we talking about that this could be used to treat?

Feng Zhang: There are about 6,000 or more diseases that are caused by faulty genes. The hope is that we will be able to address most if not all of them.

Bill Whitaker: Most if not all of them?

Feng Zhang: That’s the long-term hope.

Bill Whitaker: So we’re talking diseases like Huntington’s—

Feng Zhang: Uh-huh.

Bill Whitaker: Sickle Cell.

Feng Zhang: Yup. ALS—hemophilia.

Eric Lander: I think CRISPR, it’s fair to say, is perhaps the most surprising discovery and maybe most consequential discovery in this century so far.

lander-walk-talk-2.jpg

Eric Lander, director of the Broad Institute, speaks with correspondent Bill Whitaker

 CBS NEWS

To understand exactly what CRISPR is, we went to Eric Lander for a quick science lesson. He’s director of the Broad and Zhang’s mentor. He’s best known for being a leader of the Human Genome Project that mapped out all of our DNA, which is like a recurring sequence of letters.

Eric Lander: During the Human Genome Project, we could read out all the human DNA, and then, in the years afterwards, find the misspellings that caused human diseases. But we had no way to think about how to fix ’em. And then, pretty much on schedule, this mind-blowing discovery that bacteria have a way to fix those misspellings, appears.

Bill Whitaker: This comes from bacteria?

Eric Lander: This comes from bacteria.  Bacteria, you know, they have a problem. And they came up with a real clever solution. When they get infected by viruses, they keep a little bit of DNA, and they use it as a reminder. And they have this system called CRISPR that grabs those reminders and searches around and says, “If I ever see that again, I am gonna cut it.”

Zhang used that same bacterial system to edit DNA in human cells. Our DNA is made up of chemical bases abbreviated by the letters A, T, C, and G. As you can see in this animation from Zhang’s lab at MIT, a mutation that causes disease reads like a typo in those genetic instructions. If scientists can identify the typo, they can program CRISPR to find it and try to correct it.

Bill Whitaker: You program it? You say–

Feng Zhang: That’s right.

Bill Whitaker:  “I’m looking for this string of letters.”

Feng Zhang: Uh-huh.

Bill Whitaker: And the CRISPR will go in, and out of all of the billions and billions and billions of– of letters on your DNA, find the exact ones that you have programmed?

Feng Zhang: That’s right. CRISPR will allow you to– do many different things. You can cut it– to edit it.

Bill Whitaker: So you can snip out the bad part and you can add something that you want as well?

Feng Zhang: That’s right. You can give the cell a new piece of DNA that carries the sequence you want to incorporate into the genome.

Bill Whitaker: You say this so matter of factly. This is amazing.

Feng Zhang: It is pretty cool.

Bill Whitaker: How many other labs around the world are working with CRISPR like this?

Feng Zhang: Many. One of the things that we have been doing is to make the tool available to researchers. To date I think we have gotten it out over– 45,000 times, to 2,200 labs, in 61 countries.

Bill Whitaker: What are they doing with it?

Feng Zhang: They are using it to do everything.  A lot of applications of CRISPR. It’s really a Swiss army knife.

Cue the worldwide CRISPR frenzy. At the University of California, scientists used a form of CRISPR to edit mosquitos so they can’t transmit malaria. Their colleagues are modifying rice to better withstand floods and drought. In China, scientists tweaked a gene in beagles to make them more muscular.

crispr-full.jpg

A CRISPR vial from Zhang’s lab made its way to Dr. Kang Zhang. He is an ophthalmologist and a professor at the University of California, San Diego and wanted to see what all the hype was about.

Bill Whitaker: What did you think when you first heard of CRISPR?

Kang Zhang: I was a little bit skeptical.

Bill Whitaker: Why skeptical?

Kang Zhang: It worked so well. Too well to be believable.

He decided to experiment on mice with retinitis pigmentosa, a genetic form of blindness. He conducted a vision test using a mouse with the disease.

Bill Whitaker: This is the blind mouse?

Kang Zhang: This is the blind mouse. And– obviously, you can see that he is ignoring the rotating stripes.

His researchers injected CRISPR into the eye of another blind mouse. The CRISPR was programmed to find the main gene associated with the disease and turn it off. It takes three months to see the results.

Kang Zhang: Now, let’s see how he’s responding to the light.

Bill Whitaker: He’s following it around.

Kang Zhang: Yes.

Bill Whitaker: Look at that. You’re sure that he is seeing these lights?

Kang Zhang: This is actually a very commonly used test for vision.

Bill Whitaker: How much of their sight do they recover?

Kang Zhang: About 30, sometimes even 50% of the sight for– for mice.

The next phase of Dr. Zhang’s research is to see how CRISPR works on one of our closer relatives. He sent us this video from his lab in China where he’s studying monkeys with retinitis pigmentosa. The blind monkey ignores the food. He says this monkey was treated with CRISPR and it’s easy to see the difference. Dr. Zhang hopes to try this on humans soon.

If CRISPR is used to treat disease or make a drug it could mean big bucks. The Broad and Feng Zhang hold a primary patent for CRISPR’s use in human cells in the United States. But no technology is developed in a vacuum. Biochemist Jennifer Doudna at the University of California, Berkeley and her team made landmark CRISPR discoveries.

This week, they are challenging Zhang and the Broad in court for the rights arguing in part that Zhang’s advance was derived from her team’s breakthrough. It’s a high stakes battle. CRISPR is projected to be a multi-billion dollar market in a decade.

Bill Whitaker: Does that mean big business for you?

Feng Zhang: I think we’re– we’re still– quite a ways away from developing– CRISPR into a real therapeutic.

Bill Whitaker: I think you’re being a little bit modest. I mean this is sparking an incredible boom in biomedicine. And you’re in the center of it.

Feng Zhang: I think there is still really a lot of work that still needs to be done,  developing the systems so that they are efficient enough, making sure that they are safe enough, but these are things that– that we’re working hard to– to make possible.

“While it’s not gonna affect somebody who might be dying of a disease today, this is gonna have a real effect over the course of the next decade and couple of decades.”

But, what if it were possible to stop disease from even occurring? That sounds like science fiction, but a team of researchers in Portland, Oregon say with CRISPR, it’s now a reality.

Bill Whitaker: You correct it at the very, very earliest stages of life.

Shoukhrat Mitalipov: Right.

Bill Whitaker: In the womb.

Shoukhrat Mitalipov: Even before the womb.

Manipulating embryos has been the focus of Shoukhrat Mitalipov’s career. He runs the Center for Embryonic Cell and Gene Therapy at Oregon Health and Science University. Mitalipov is a maverick. He regularly makes headlines with his innovative, sometimes controversial methods to prevent genetic disease.

Shoukhrat Mitalipov: Preventing is always more effective– so there would be no– no recurrence of new disease. Particularly when we’re talking about heritable– diseases that parents pass to children.

So Mitalipov and an international team of scientists decided to use CRISPR on human embryos to correct a single genetic mutation that causes a deadly heart disease called hypertropic cardiomyopathy.

They got healthy eggs from donors and sperm from a man who carries the disease. At the same time the eggs are fertilized, they also get an injection of CRISPR. Mitalipov enlarged the microscopic procedure over three hundred times so we could see it.

Shoukhrat Mitalipov: Here we have our pipette with sperm inside, which has been already exposed to CRISPR.  And this is a egg. And so what we need to do is pierce through, and then we break membrane. And now –

Bill Whitaker: Release the sperm into the egg.

Shoukhrat Mitalipov: Yeah. And now this is the sperm coming in.

Bill Whitaker: Wow.

Shoukhrat Mitalipov: Now it’s inside there.

Bill Whitaker: Just like that, that egg has been CRISPRed?

Shoukhrat Mitalipov: CRISPRed, fertilized.

Bill Whitaker: And you have changed the genetic destiny of that embryo.

Shoukhrat Mitalipov: Yes, we believe so.

These embryos will never be implanted, but they are grown in an incubator for three days and then checked to see if they carry the disease mutation.

Normally, 50 percent would. Mitalipov says with CRISPR, 72 percent were free of the mutation that would cause the heart disease.

Bill Whitaker: This is a huge– advance in science and medicine.

Shoukhrat Mitalipov: We hope so. I think we– we’re still kind of in the early stages. I wouldn’t say that we are ready to– to go to clinics now.

He knows his results have to be replicated by an outside lab before they’re accepted by the scientific community. But if they hold up, one day CRISPR could be used to help families that have been plagued by inherited disease for generations.

Bill Whitaker: Is that what drives you?

Shoukhrat Mitalipov: Yes. Of course, it’s a suffering of children, but also the guilt the parents have at saying, “I passed it to my child.” So it’s like, “I caused this disease.” And I think now, we have a tool where we could help these families.

Mitalipov wants to use CRISPR to eliminate disease, but the concern is his research has created a blueprint for less scrupulous doctors to design human beings – to edit embryos to make babies that are smarter, taller, stronger. Mitalipov says that’s not even possible right now.

Bill Whitaker: Your critics say that you’re playing God.

Shoukhrat Mitalipov: I think– you could say to– to every treatment that they– humans and doctors develop that– we– we’re playing God. God gave us brains so we could find a way to eliminate suffering of human beings. And if that’s– you know, playing God, I guess that’s the way it is.

Bill Whitaker: So what do you think about editing an embryo to prevent disease?

Feng Zhang: We don’t really understand how complicated biology is. There’s a gene called PCSK9. If you remove PCSK9, you can reduce cardiovascular disease, heart attack– risks significantly. But it also has been shown recently to increase risk for diabetes. So how do you make the judgment call between these tradeoffs? And there will likely be other—impacts we haven’t yet identified. So I think we need to wait and be more cautious.

Eric Lander: I don’t think we’re close to ready to use it to go edit the human population. I think we’ve gotta use it for medicine for a while. I think those are the urgent questions. That’s what people want right now, is they want cures for disease.

Those urgent questions might soon be answered. A small clinical trial, the first in the U.S. using CRISPR to target certain types of cancer, is now enrolling patients.

Eric Lander: I wanna always balance hope versus hype here. While it’s not gonna affect somebody who might be dying of a disease today, this is gonna have a real effect over the course of the next decade and couple of decades. And for the next generation, I think it’ll be transformative.

Produced by Nichole Marks. Associate producers, Kate Morris and Jaime Woods.